Cyclic dipeptides are widely used as models for larger peptides because of
their simplicity and limited conformational freedom. Some cyclic dipeptides
have been shown to be antiviral, antibiotic and anti-tumour. The aim of th
is study was to determine the biological activity of four cyclic dipeptides
synthesized in this lab oratory: cyclo(L-phenylalanyl-L-prolyl), cyclo(L-t
yrosyl-L-prolyl), cyclo(L-tryptophanyl-L-prolyl) and cyclo(L-tryptophanyl-L
-tryptophanyl).
The enhancement or inhibition of calcium channels in ventricular myocytes f
rom rats and delayed-rectifier potassium channels in ventricular myocytes f
rom guinea-pigs were determined by use of the whole-cell patch-clamp techni
que. The induction of differentiation in HT-29 cells was assessed by assayi
ng for an increase in the expression of alkaline phosphatase. Antibiotic pr
operties against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneum
oniae, Staphylococcus aureus, Bacillus subtilus and Streptococcus sp. were
determined by use of the Kirby-Bauer disc-diffusion assay. Results from,the
se assays indicate that the cyclic dipeptides have biological activity in b
oth prokaryotes and eukaryotes. Three of the dipeptides block cation channe
ls in ventricular myocytes and all increase the expression of alkaline phos
phatase. All the dipeptides have concentration-dependent antibacterial prop
erties.
These results suggest that with increased solubility the cyclic dipeptides
might have potential as muscle relaxants, anti-tumour compounds and antibio
tics.